CG
CLVS

Cutler Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Cutler Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,800
Closed -$30K – 5599
2022
Q3 		$30K Sell
17,800
-11,500
-39% -$17.9K ﹤0.01% 2313
2022
Q2 		$42K Sell
29,300
-8,100
-22% -$11.9K ﹤0.01% 2085
2022
Q1 		$94K Buy
+37,400
New +$73.5K 0.01% 1755
2020
Q4 		– Sell
-5,400
Closed -$3K – 5720
2020
Q3 		$3K Buy
+5,400
New +$32.3K ﹤0.01% 3951
2020
Q2 		– Sell
-600
Closed -$11K – 5087
2020
Q1 		$11K Sell
600
-3,000
-83% -$24.1K ﹤0.01% 2691
2019
Q4 		$21K Buy
+3,600
New +$26.2K ﹤0.01% 2198
2019
Q1 		– Sell
-29,600
Closed -$56K – 4979
2018
Q4 		$56K Buy
29,600
+17,000
+135% +$347K 0.01% 1400
2018
Q3 		$176K Sell
12,600
-400
-3% -$15.5K 0.01% 907
2018
Q2 		$82K Sell
13,000
-7,300
-36% -$355K 0.01% 1288
2018
Q1 		$83K Sell
20,300
-50,200
-71% -$2.93M 0.01% 1326
2017
Q4 		$115K Sell
70,500
-23,800
-25% -$1.66M ﹤0.01% 1287
2017
Q3 		$102K Buy
94,300
+1,800
+2% +$143K ﹤0.01% 1662
2017
Q2 		$103K Buy
92,500
+28,800
+45% +$1.76M ﹤0.01% 1838
2017
Q1 		$139K Sell
63,700
-24,600
-28% -$1.5M 0.01% 1469
2016
Q4 		$1.15M Buy
88,300
+33,800
+62% +$1.19M 0.04% 365
2016
Q3 		$140K Buy
54,500
+41,700
+326% +$895K 0.01% 1523
2016
Q2 		$231K Sell
12,800
-46,000
-78% -$672K 0.01% 1012
2016
Q1 		$1.54M Sell
58,800
-3,000
-5% -$63.5K 0.1% 168
2015
Q4 		$1.87M Buy
+61,800
New +$3.99M 0.1% 175

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cutler Group's CLVS Position: Q4 2022 in Review

Cutler Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 14,569 shares — an estimated $17K sold.

Cutler Group first reported a position in CLVS in Q4 2015 and held it in 21 quarters. The position peaked at $3.09M in Q4 2016. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Cutler Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 14,569 Clovis Oncology, Inc. shares in Q4 2022, an estimated $17K.
  • Cutler Group first reported a position in Clovis Oncology, Inc. in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Clovis Oncology, Inc. position peaked at $3.09M in Q4 2016.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.